热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse CD62L Antibody
产品名称：
FITC anti-mouse CD62L Antibody
产品类别：
抗体
产品编号：
104405
产品应用：
104405
[价格]
规格 价格 库存
50µg ￥ 780 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References

(PubMed link indicates BioLegend citation)
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  2. Furuya Y, et al. 2014. J Virol. 88:9166. PubMed
  3. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  4. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  5. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  6. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  7. Israelow B, et al. 2021. Sci Immunol. 6:eabl4509. PubMed
  8. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  9. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  10. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  11. Burrack AL, et al. 2019. Cell Rep. 28:2140. PubMed
  12. Kubo M, et al. 2018. Oncol Rep. 39:417. PubMed
  13. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  14. Chen Z, et al. 2017. Mucosal Immunol. 10:58. PubMed
  15. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  16. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  17. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  18. Prüfer S, et al. 2014. Immunobiology. 219:87. PubMed
  19. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  20. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  21. McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
  22. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  23. Cuburu N, et al. 2019. J Immunol. 202:1250. PubMed
  24. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  25. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  26. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  27. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  28. Cutler CE, et al. 2019. Glycobiology. 29:776. PubMed
  29. Wan X, et al. 2018. Nature. 560:107. PubMed
  30. Kishore M et al. 2017. Immunity. 47(5):875-889 . PubMed
  31. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  32. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  33. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  34. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  35. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  36. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  37. Nowill AE, et al. 2019. J Immunol. 203:1298. PubMed
  38. Joubert IA, et al. 2020. Vaccine. 38:1015. PubMed
  39. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  40. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  41. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  42. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  43. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  44. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  45. Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed
  46. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  47. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  48. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  49. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  50. Stienne C, et al. 2022. Cell Rep. 38:110553. PubMed
  51. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  52. Mohammed RN, et al. 2019. Sci Rep. 4.185416667. PubMed
  53. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
RRID
AB_313092 (BioLegend Cat. No. 104405) AB_313093 (BioLegend Cat. No. 104406)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线